- Home
- PFL vs TMCI Comparison
PFL vs TMCI Comparison
Compare PFL & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFL
- TMCI
- Stock Information
- Founded
- PFL 2003
- TMCI 2014
- Country
- PFL United States
- TMCI United States
- Employees
- PFL N/A
- TMCI N/A
- Industry
- PFL Finance Companies
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PFL Finance
- TMCI Health Care
- Exchange
- PFL Nasdaq
- TMCI Nasdaq
- Market Cap
- PFL 332.7M
- TMCI 329.0M
- IPO Year
- PFL N/A
- TMCI 2021
- Fundamental
- Price
- PFL $8.30
- TMCI $7.61
- Analyst Decision
- PFL
- TMCI Hold
- Analyst Count
- PFL 0
- TMCI 6
- Target Price
- PFL N/A
- TMCI $7.40
- AVG Volume (30 Days)
- PFL 113.7K
- TMCI 785.2K
- Earning Date
- PFL 01-01-0001
- TMCI 11-05-2024
- Dividend Yield
- PFL 11.53%
- TMCI N/A
- EPS Growth
- PFL N/A
- TMCI N/A
- EPS
- PFL N/A
- TMCI N/A
- Revenue
- PFL N/A
- TMCI $202,861,000.00
- Revenue This Year
- PFL N/A
- TMCI $13.15
- Revenue Next Year
- PFL N/A
- TMCI $8.36
- P/E Ratio
- PFL N/A
- TMCI N/A
- Revenue Growth
- PFL N/A
- TMCI 16.14
- 52 Week Low
- PFL $6.98
- TMCI $3.92
- 52 Week High
- PFL $8.62
- TMCI $15.98
- Technical
- Relative Strength Index (RSI)
- PFL 30.61
- TMCI 68.82
- Support Level
- PFL $8.16
- TMCI $7.58
- Resistance Level
- PFL $8.60
- TMCI $8.37
- Average True Range (ATR)
- PFL 0.08
- TMCI 0.45
- MACD
- PFL -0.03
- TMCI 0.21
- Stochastic Oscillator
- PFL 31.82
- TMCI 80.26
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.